Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Jiangbo Pharmaceuticals woos pharma distributor Xinkangqi Medical

This article was originally published in Scrip

Executive Summary

Jiangbo Pharmaceuticals, the NASDAQ-quoted Chinese pharma company, has unveiled plans to acquire Xinkangqi Medical, a regional wholesale drug distributor in Shandong Province, the home to 94 million people. A final price will be determined once Jiangbo has completed its due diligence, which is expected to conclude within three months. Jiangbo will retain Xinkangqi's current employees and management team when the acquisition closes by the end of September 2011.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts